Fut, nem toboroz1. fázis
A Phase 1 Study to Determine the Safety, Tolerability and Pharmacokinetics of 177Lu-EVG321 in Patients with Small Cell Lung Cancer
Key facts
- Where
- Innsbruck, AusztriaSee the site
- Phase
- 1. fázis
Where in Ausztria
- Medizinische Universitaet InnsbruckInnsbruck, AusztriaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Evergreen Theragnostics Inc.
- Trial code
- EU 2024-518039-12-00
- Record updated
- 2026. augusztus 10.